|
Pfizer, Boehringer's Drug Helped to Delay Asthma Attacks
Businessweek A lung drug from Boehringer Ingelheim GmbH and Pfizer Inc. (PFE) helped delay severe episodes in asthma patients, researchers said today in two studies that may result in broader use of the medicine. Spiriva, known chemically as tiotropium, cut the … First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated … Phase III results: tiotropiumA Respimat® significantly reduces exacerbations … |
View full post on asthma – Google News